MAP3K3

From WikiMD's Wellness Encyclopedia

MAP3K3

MAP3K3, also known as Mitogen-Activated Protein Kinase Kinase Kinase 3, is a serine/threonine kinase that plays a crucial role in the MAPK/ERK signaling pathway. This enzyme is encoded by the MAP3K3 gene in humans and is involved in various cellular processes, including cell growth, differentiation, and response to stress.

Structure[edit | edit source]

MAP3K3 is a member of the MAP kinase kinase kinase (MAP3K) family, which is characterized by a conserved kinase domain. The protein structure includes an N-terminal regulatory domain, a central kinase domain, and a C-terminal region that may be involved in protein-protein interactions. The kinase domain is responsible for its enzymatic activity, phosphorylating downstream MAP kinase kinases (MAP2Ks).

Function[edit | edit source]

MAP3K3 functions as an upstream activator in the MAPK signaling cascade. It specifically phosphorylates and activates MAP2Ks, which in turn activate MAPKs. This signaling cascade is essential for transmitting extracellular signals to the nucleus, resulting in gene expression changes that drive cellular responses.

MAP3K3 is involved in several key cellular processes:

  • Cell Proliferation and Differentiation: By activating the MAPK/ERK pathway, MAP3K3 influences cell cycle progression and differentiation.
  • Stress Response: MAP3K3 is activated in response to various stress stimuli, including oxidative stress and inflammatory cytokines, leading to the activation of stress-activated protein kinases (SAPKs).
  • Apoptosis: It can also play a role in apoptotic signaling pathways, contributing to programmed cell death under certain conditions.

Clinical Significance[edit | edit source]

Dysregulation of MAP3K3 has been implicated in various diseases, including cancer and inflammatory disorders. Overexpression or mutations in MAP3K3 can lead to aberrant activation of the MAPK pathway, contributing to oncogenesis. Inhibitors targeting MAP3K3 and its downstream effectors are being explored as potential therapeutic agents in cancer treatment.

Research and Development[edit | edit source]

Ongoing research is focused on understanding the precise regulatory mechanisms of MAP3K3, its interaction with other signaling molecules, and its role in disease pathogenesis. Advances in structural biology and molecular biology techniques are aiding in the development of specific inhibitors that could modulate MAP3K3 activity for therapeutic purposes.

Also see[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD